Skip to main content

Table 1 STZ Rat Characteristics

From: Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment

 

Blood glucose concentrations (mg/dl)

Body weight (g)

  

Day 0

Day 3

Day 7

Day 14

End

Day 3

End

Trial 1 (8 wks)

Control

 

78 ± 5

  

68 ± 5

270 ± 7

426 ± 18

 

STZ

 

357 ± 24

  

365 ± 12

237 ± 5

297 ± 18

Trial 2 (2 wks)

Control

53 ± 3

75 ± 5

76 ± 4

62 ± 4

 

302 ± 3

359 ± 5

 

STZ

49 ± 1

363 ± 17

357 ± 24

297 ± 20

 

274 ± 7

299 ± 9

 

STZ + Ins

49 ± 2

147 ± 46

104 ± 38

43 ± 1

 

290 ± 6

356 ± 7

Trial 3 (6 wks)

Control

51 ± 1

74 ± 4

77 ± 3

65 ± 4

68 ± 3

314 ± 4

467 ± 12

 

STZ

48 ± 1

348 ± 23

315 ± 43

305 ± 32

300 ± 6

276 ± 4

347 ± 18

 

STZ + Ins

48 ± 2

214 ± 35

60 ± 21

47 ± 3

69 ± 16

278 ± 5

450 ± 6

Trial 4 (6 wks)

Control

 

N/A

  

65 ± 7

N/A

455 ± 27

 

STZ

 

377 ± 10

  

340 ± 60

318 ± 3

327 ± 51

 

STZ + LA

 

369 ± 13

  

322 ± 44

304 ± 4

306 ± 32